Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride on Emotional Processing in Healthy Volunteers
NCT03863366Completed
- Sponsor
- University of Oxford
- Start
- Feb 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of prucalopride in major depressive disorder (MDD), sponsored by University of Oxford. Primary endpoint: Recognition of positive and negative facial expressions. Started Feb 2017; status: completed.
02
Drugs
prucalopride
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03863366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03863366.